安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Geron | Working to change the course of blood cancers
Geron is tirelessly pursuing blood cancer treatments with the potential to extend and enhance lives
- Our story continues to evolve - Geron
For more than 30 years, Geron has tirelessly dedicated itself to the pursuit of new therapies for patients with blood cancers
- Geron Corporation - Investors Media
Geron is a commercial-stage biopharmaceutical company with a first-in-class telomerase inhibitor that is approved in the United States for the treatment of certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia
- Our tireless pursuit | Geron
With a seasoned leadership team with world-class expertise spanning research, clinical development, regulatory, manufacturing and commercial experience in hematologic malignancies, Geron is prepared to deliver on our mission to change lives by changing the course of blood cancer
- Geron Corporation - Geron Announces FDA Approval of RYTELO™ (imetelstat . . .
Geron is a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer Our first-in-class telomerase inhibitor RYTELO™ (imetelstat) is FDA-approved for the treatment of adult patients with lower-risk MDS with transfusion dependent anemia
- Advancing how blood cancers are treated | Geron
Geron is exploring the broad potential of telomerase inhibition across multiple hematologic malignancies
- Clinical trials exploring imetelstat - Geron
Geron sponsored trials IMpactMF, our pivotal Phase 3 clinical trial in JAK inhibitor relapsed refractory MF, is an open label, 2:1 randomized, controlled clinical trial of imetelstat to evaluate a potential improvement in overall survival compared to best available therapy
- Medicines - Geron
Geron is a commercial stage biopharmaceutical company commercializing a first-in-class telomerase inhibitor for relapsed refractory myelodysplastic syndromes
|
|
|